🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate whether specific lipoprotein(a) apheresis on the top of optimal...
Status
Completed
Location
Russian Cardiology Research and Production Center
Start Date
2009-09
Trial ID
NCT02133807
Treatments Being Tested
To evaluate the efficacy of subcutaneous (SC) evolocumab, compared to regul...
Status
Completed
Location
Research Site
Start Date
2015-12-21
Trial ID
NCT02585895
Treatments Being Tested
This multicenter multinational prospective two-arm matched-pair observation...
Status
Unknown
Location
University Hospital Carl Gustav Carus
Start Date
2016-08
Trial ID
NCT02791802
The primary objective of the study is to demonstrate that the performance o...
Status
Completed
Location
Hartford Hospital
Start Date
2007-08
Trial ID
NCT00526058
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of immunoads...
Status
Completed
Location
Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine
Start Date
2000-01
Trial ID
NCT00302510
Treatments Being Tested
The clinical Investigation will be performed to compare the safety and effe...
Status
Completed
Location
Nephrocare Rostock GmbH
Start Date
2018-12-28
Trial ID
NCT03795038
Treatments Being Tested
Homozygous familial hypercholesterolemia (HoFH) is characterized by a six- ...
Status
Completed
Location
Institute of Nutrition and Functional Foods (INAF)
Start Date
2013-04
Trial ID
NCT02286596
Treatments Being Tested
The primary objective of the study is to evaluate the effect of alirocumab ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-31
Trial ID
NCT02326220
Treatments Being Tested
Lipoprotein apheresis is often applied as the final treatment of patient wi...
Status
Unknown
Location
Carl Gustav Carus University Hospital Dresden, Technische Universität Dresden,
Start Date
2014-10-01
Trial ID
NCT05181969
Lipoprotein(a) \[Lp(a)\] is an independent risk factor for cardiovascular d...
Status
Withdrawn
Location
Lipidambulanz, Interdisziplinäres Stoffwechsel-Centrum, CVK, Charite
Start Date
2010-09
Trial ID
NCT01064934
Treatments Being Tested